Comparison of targeted next generation sequencing assays in non-small cell lung cancer patients
Abstract Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer the mutational spectrum of which has been extensively characterized. Treatment of patients with NSCLC based on their molecular profile is now part of the standard clinical care. The aim of this study was firstly to...
Saved in:
Main Authors: | Ieva Drejeriene, Jurate Gruode, Saulius Cicenas, Charalambos Loizides, Alexia Eliades, Achilleas Achilleos, Elena Kypri, Kyriakos Tsangaras, Marios Ioannides, George Koumbaris, Diana Stanciute, Arnoldas Krasauskas, Philippos C. Patsalis |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-12-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-024-01640-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Stereotactic Body Radiotherapy in Oligometastatic Non-Small Cell Lung Cancer
by: Benson Wan, et al.
Published: (2024-12-01) -
Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissues
by: Qikang Hu, et al.
Published: (2023-12-01) -
Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01) -
Responsive afatinib treatment in high-grade salivary gland ductal carcinoma and NSCLC with uncommon EGFR mutations: Treatment outcomes
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer
by: Qian Dai, et al.
Published: (2024-12-01)